Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.

jun wada,hong zhang,yoshinori tsuchiyama,keita hiragushi,kazuyuki hida,kenichi shikata,yashpal s kanwar,hirofumi makino

DOI: https://doi.org/10.1046/j.1523-1755.2001.0590041363.x

IF: 19.6

2001-01-01

Kidney International

Abstract:Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.

What problem does this paper attempt to address?

Comparison Of Glomerular And Podocyte Mrna Profiles In Streptozotocin-Induced Diabetes

Jia Fu,Chengguo Wei,Kyung Lee,Weijia Zhang,Wu He,Peter Chuang,Zhihong Liu,John Cijiang He

DOI: https://doi.org/10.1681/ASN.2015040421

IF: 14.978

2016-01-01

Journal of the American Society of Nephrology

Abstract:Evaluating the mRNA profile of podocytes in the diabetic kidney may indicate genes involved in the pathogenesis of diabetic nephropathy. To determine if the podocyte-specific gene information contained in mRNA profiles of the whole glomerulus of the diabetic kidney accurately reflects gene expression in the isolated podocytes, we crossed Nos3(-/-) IRG mice with podocin-rtTA and TetON-Cre mice for enhanced green fluorescent protein labeling of podocytes before diabetic injury. Diabetes was induced by streptozotocin, and mRNA profiles of isolated glomeruli and sorted podocytes from diabetic and control mice were examined 10 weeks later. Expression of podocyte-specific markers in glomeruli was downregulated in diabetic mice compared with controls. However, expression of these markers was not altered in sorted podocytes from diabetic mice. When mRNA levels of glomeruli were corrected for podocyte number per glomerulus, the differences in podocyte marker expression disappeared. Analysis of the differentially expressed genes in diabetic mice also revealed distinct upregulated pathways in the glomeruli (mitochondria) function, oxidative stress) and in podocytes (actin organization). In conclusion, our data suggest reduced expression of podocyte markers in glomeruli is a secondary effect of reduced podocyte number, thus podocyte-specific gene expression detected in the whole glomerulus may not represent that in podocytes in the diabetic kidney.
Specific Changes of Somatostatin Mrna Expression in the Frontal Cortex and Hippocampus of Diabetic Rats

XM Zhang,X Zhu,F Shen,JL Zhou

DOI: https://doi.org/10.1111/j.0021-8782.2004.00273.x

2004-01-01

Journal of Anatomy

Abstract:Most current studies of diabetic encephalopathy have focused on brain blood flow and metabolism, but there has been little research on the influence of diabetes on brain tissue and the causes of chronic diabetic encephalopathy. The technique of molecular biology makes it possible to explore the mechanism of chronic diabetic encephalopathy by testing the distribution of somatostatin in the brain. We have therefore analysed, by in situ hybridization histochemistry, the changes in somatostatin (SST) mRNA in the frontal cortex and hippocampus of rats made diabetic by the injection of streptozotocin. Ten Sprague-Dawley control rats were compared with ten streptozotocin-induced diabetic rats. The weight, blood glucose and urine glucose did not differ between the two groups before the injection of streptozotocin. Four weeks after the injection of streptozotocin the weight, blood glucose and urine glucose of the diabetic rats were, respectively, 199.1 +/- 15.6 g, 23.7 +/- 3.25 mmol L-1 and (++) to (+++) whereas those of the control group were 265.5 +/- 30.3 g, 4.84 +/- 0.63 mmol L-1 and (-). Somatostatin mRNA was reduced in the diabetic rats. The number of SST mRNA-positive neurons and the optical density of positive cells in the hippocampus and frontal cortex of the diabetic rats were 80.6 +/- 17.5 mm(-2) and 76.5 +/- 17.6 compared with 150.5 +/- 21.1 mm(-2) and 115.1 +/- 18.5 in the control rats. The induction of diabetes is thus associated with a decreased expression of SST mRNA in the hippocampus and frontal cortex, which might be an important component of chronic diabetic encephalopathy.
Expression Changes Of Mitogen-Actilvated Protelin Kinase Phosphatase-1 (Mkp-1) In Myocardium Of Streptozotocin-Induced Diabetic Rats

Y. Weng,F. Shen,J. Li,Y. Shen,X. Zhang

DOI: https://doi.org/10.1055/s-2007-973060

2007-01-01

Experimental and Clinical Endocrinology & Diabetes

Abstract:MAP Kinase Phosphatase-1 (MKP-1) is a dual specific phosphatase selective for MAP kinases, and was believed to implicate in the development of cardiac hypertrophy. However, whether MKP-1 is involved in the pathogenesis of diabetic cardiomyopathy is still unknown. We employed streptozotocin (STZ)-induced diabetic SpragueDawley rats to study the alteration of the MKP-1 expressions in the left ventricular myocardium in diabetic and normal groups by immunchistochernistry and real-time quantitative reverse transcription-polymerase chain reaction. The weight, blood sugar and urine sugar were measured before and after model induction in both control and diabetic groups. Changes of heart ultrastructure were analyzed by using transmission electron microscopy. The data of weight, blood sugar and urine sugar indicated no significant difference between the two groups before animal model induction. Eight weeks after the induction of diabetes, the differences between the control and the diabetic groups in weight, blood sugar and urine sugar were significant (P < 0.01). When compared with control, diabetic myocardium ultrastructural changes included myofibrillar disarrangements, mitochondria disruption, and increase in nuclear membrane invaginations. A significant decrease of MKP1 expression was observed in the diabetic rats' myocardium (P < 0.01). Our study provides experimental evidences that hyperglycernia could damage myocardial ultrastructure. Moreover, we provided first evidence that down-regulation of cardio protective peptide MKP-1, the MAPK pathway negative regulator, in myocardium of streptozotocin-induced diabetic rats, which may contribute to the deterioration of cardiac function and lead to diabetic cardiomyopathy.
Studies on somatostatin mRNA expression in frontal cortex of diabetic rats model]

Xiao Ming Zhang,Xi Zhu,Zhang Gen Yuan,Guo Liang Ren,Ji Cheng Li

DOI: https://doi.org/10.3321/j.issn:1673-520X.2003.03.009

2003-01-01

Abstract:To study the changes of somatostatin (SST) in frontal cortex of the brain of quick streptozotocin-induced diabetes rats. We established the quick-diabetic rats model by injecting streptozotocin intraperitoneally with 60 mg/kg and compared the changes of SST in frontal cortex of diabetic model with normal rats by using in situ hybridization and computer image analysis. The number, light density and the average area of positive cells in frontal cortex of diabetic model were reduced significantly in comparison with those of normal rats (P < 0.01). These results indicated that the decline of SST mRNA expression in frontal cortex may relate to chronic diabetes encephalopathy.
Gene expression profiling in glomeruli of diabetic nephropathy rat

Qian Zhang,Xinhua Xiao,Ming Li,Wenhui Li,Miao Yu,Huabing Zhang,Xiaofang Sun,Lili Mao,Hongding Xiang

DOI: https://doi.org/10.1258/ebm.2012.012032

2012-08-01

Experimental Biology and Medicine

Abstract:Diabetic nephropathy (DN) remains the most common cause of end-stage renal disease (ESRD) as the burden of diabetes increases worldwide. To find improved intervention strategies for this disease, it is necessary to investigate the molecular mechanisms involved. To obtain more insight into processes that lead to DN, mRNA expression profiles of diabetic and normal glomeruli from rat kidneys were compared. Rats were divided into a control group and a DN group randomly. The DN group was injected with streptozotocin. Fasting blood glucose (FBG) and weight were measured monthly. On the 12th week, blood samples were collected and analyzed for plasma creatinine and blood urea nitrogen (BUN). Glomeruli were isolated and Illumina Rat Ref-12 V1.0 Expression Beadchip gene array was performed. Quantitative realtime polymerase chain reaction (Q-RT-PCR) was used to confirm the results of gene array for a selected number of genes. We found FBG, 24-h urinary albumin, serum creatinine and BUN were significantly increased, while urinary creatinine and body weight were significantly decreased in the DN group. Glomeruli from the DN group had 624 genes with differential expression. DAVID (Database for Annotation, Visualization and integrated Discovery) analysis showed that the three most enriched terms were ‘cytosol’ (GO:0005829), ‘translational elongation’ (GO:0006414) and ‘mitochondion’ (GO:0005739). Those genes could be mapped to eight pathways. The most common type of enriched pathway was related to ‘extracellular matrix (ECM)-receptor interaction’. Other pathways included those for ‘ribosome’, ‘focal adhesion’, ‘oxidative phosphorylation’, ‘transforming growth factor (TGF)-beta signaling pathway’, ‘Parkinson's disease’, ‘Alzheimer's disease’ and ‘renin–angiotensin system’. Q-RT-PCR verified that Atp5b (F1-ATPase beta subunit), Col1a1 (collagen type 1 alpha 1), Cox6c (cytochrome c oxidase subunit VIc), Ndufs3 (NADH dehydrogenase [ubiquinone] Fe-S protein 3) and Tgfb1 (transforming growth factor β1) were significantly up-regulated in the DN group. The expressions of NDUFS3 and TGF- β1 in DN rats were increased. Our findings suggested that the oxidative phosphorylation pathway, ECM-receptor interaction, TGF- β pathway and renin–angiotensin system may be involved in the development of DN.

medicine, research & experimental
Study on Gene Expression Profile in Renal Cortex in STZ Induced Diabetic Nephropathy Rats by Cdna Microarray (Genechip)

CUI Chun-li,LI Su,XIAO Zi-li,LI Yao,CHEN Guo-qing,MAO Yu-min

DOI: https://doi.org/10.3969/j.issn.1008-0392.2001.02.005

2001-01-01

Abstract:Objective To study the gene expression profile in STZ induced diabetic rats and to analyze differential gene expression patterns between normal and diabetic rats in large scale.Methods (1) Experimental diabetic nephropathy was induced by streptozotocin in S D male rats. Kidney biopsies were obtained from control (citrate injected) and diabetic rats at day 60; (2) The fluorescent labeled DNA probes were prepared from mRNA, which were extracted from both the renal cortex of the control and the diabetic rats; (3) Two kinds of probes were then hybridized against BioDoor Genechip including 1 500 reported genes and 2 500 unreported genes, the fluorescent signals were scanned and analyzed.Results (1) There were about 8.4% genes altered in gene expression profile, the expression level of 12 genes were down regulated while 323 genes were up regulated significantly in renal corted in diabetic rats; (2) The reported genes changed in both the normal and the diabetic rats accounting 18.8% in the total differential expression genes.Conclusion Combined with animal model, gene chip could be used to analyze gene expression profile in diabetes, as well to screen diseases associated genes. So the genechip technology can play an important role in exploring disease mechanism at genetic level.
Gene expression of proteins handling the calcium homeostasis in the diabetic rat heart

周斌全,胡申江

DOI: https://doi.org/10.3321/j.issn:1000-4718.2004.09.013

2004-01-01

Abstract:AIM: To investigate the gene expression of proteins handling the calcium homeostasis in diabetic rat heart. METHODS: Diabetes was induced in male Sprague-Dawley rats (180-220)g by administering a single tail-vein injection (40mg/kg ) of alloxan, and the control group was injected with normal saline. At the end of four, six weeks after the induction of diabetes, the animals were killed for assessment of the ventricular gene expression of proteins handling the calcium homeostasis which was measured by reverse transcription-polymerase chain reaction and nomalized to the mRNAs level of actin. RESULTS: At the end of 4 and 6 weeks, the weight of body and the heart in the diabetic group is lower than that in control rats, heart to body weight of diabetic rats is higher than control. No changes in mRNAs level of sarcoplasmic reticulum calcium ATPase, phospholamban, ryanodine receptor type 2, 1,4,5-trisphosphate inositol receptor type 2 were observed 4 weeks after alloxan injection. Expression of phospholamban mRNAs was significantly increased, but ryanodine receptor type 2, 1,4,5-trisphosphate inositol receptor type 2 mRNAs were significantly decreased than that in the age-matched controls. In contrast, expression of mRNAs coding sarcoplasmic reticulum calcium ATPase was not affected 6 weeks after alloxan injection. CONCLUSION: Gene expression of phospholamban is increased while ryanodine receptor type 2, 1,4,5-trisphosphate inositol receptor type 2 are decreased in the diabetic rat heart. [
Changes of TGF - β1 , Vimentin and Desmin Gene Expression in the Renal Cortex of Streptozotocin - induced Diabetic Rats

叶迅,李红,张晋红,赵晓霞

DOI: https://doi.org/10.3969/j.issn.1673-548X.2006.09.010

2006-01-01

Abstract:Objective To study the expression of TGF-β_1 , vimentin and desmin gene in the renal cortex of STZ induced diabetic rats. Methods Diabetes was induced in 32 male SD rats by single intraperitoneal injection of 1.0%STZ (70mg/kg). 36 age and weight, sex matched SD rats used as controls. The expression of TGF-β_1 , vimentin and desmin mRNA in the renal cortex were detected by RT-PCR on the 3~ rd , the 7~ th , the 14~ th , the 30~ th , the 60~ th and the 90~ th days after the DM rat model established. Results The expression of TGF-β_1 , vimentin mRNA in the renal cortex of diabetic rats gradually increased respectively from the 7~ th day and the 14~ th day after the model established, and the expressive intensity was significantly greater than that in controls (P<0.05 or P<0.01). However, the expression of desmin mRNA in the renal cortex of diabetic rats gradually decreased from the 14~ th day after the model established, and the expressive intensity was significantly less than that in controls (P<0.05 or P<0.01). ② The expression level of TGF-β_1 mRNA correlated positively to that of vimentin mRNA in the renal cortex of diabetic rats, while the expression level of desmin mRNA correlated negatively to that of TGF-β_1 mRNA and to that of vimentin mRNA in the renal cortex of diabetic rats. Conclusions There may be partial transformation of renal tubular epithelial into fibroblast and TGF-β may play a role in this transformation during the progressive interstitial fibrosis of diabetic nephropathy.
Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease

Jia Fu,Kemal M. Akat,Zeguo Sun,Weijia Zhang,Detlef Schlondorff,Zhihong Liu,Thomas Tuschl,Kyung Lee,John Cijiang He

DOI: https://doi.org/10.1681/asn.2018090896

IF: 14.978

2019-01-01

Journal of the American Society of Nephrology

Abstract:Background Recent single-cell RNA sequencing (scRNA-seq) analyses have offered much insight into cell-specific gene expression profiles in normal kidneys. However, in diseased kidneys, understanding of changes in specific cells, particularly glomerular cells, remains limited. Methods To elucidate the glomerular cell-specific gene expression changes in diabetic kidney disease, we performed scRNA-seq analysis of isolated glomerular cells from streptozotocin-induced diabetic endothelial nitric oxide synthase (eNOS)-deficient (eNOS(-/-)) mice and control eNOS(-/-) mice. Results We identified five distinct cell populations, including glomerular endothelial cells, mesangial cells, podocytes, immune cells, and tubular cells. Using scRNA-seq analysis, we confirmed the expression of glomerular cell-specific markers and also identified several new potential markers of glomerular cells. The number of immune cells was significantly higher in diabetic glomeruli compared with control glomeruli, and further cluster analysis showed that these immune cells were predominantly macrophages. Analysis of differential gene expression in endothelial and mesangial cells of diabetic and control mice showed dynamic changes in the pattern of expressed genes, many of which are known to be involved in diabetic kidney disease. Moreover, gene expression analysis showed variable responses of individual cells to diabetic injury. Conclusions Our findings demonstrate the ability of scRNA-seq analysis in isolated glomerular cells from diabetic and control mice to reveal dynamic changes in gene expression in diabetic kidneys, with variable responses of individual cells. Such changes, which might not be apparent in bulk transcriptomic analysis of glomerular cells, may help identify important pathophysiologic factors contributing to the progression of diabetic kidney disease.
Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects

Stephanie A Eid,Lucy M Hinder,Hongyu Zhang,Ridvan Eksi,Viji Nair,Sean Eddy,Felix Eichinger,Meeyoung Park,Jharna Saha,Celine C Berthier,Hosagrahar V Jagadish,Yuanfang Guan,Subramaniam Pennathur,Junguk Hur,Matthias Kretzler,Eva L Feldman,Frank C Brosius

DOI: https://doi.org/10.1096/fj.202002387R

Abstract:Diabetic kidney disease (DKD) and diabetic peripheral neuropathy (DPN) are two common diabetic complications. However, their pathogenesis remains elusive and current therapies are only modestly effective. We evaluated genome-wide expression to identify pathways involved in DKD and DPN progression in db/db eNOS-/- mice receiving renin-angiotensin-aldosterone system (RAS)-blocking drugs to mimic the current standard of care for DKD patients. Diabetes and eNOS deletion worsened DKD, which improved with RAS treatment. Diabetes also induced DPN, which was not affected by eNOS deletion or RAS blockade. Given the multiple factors affecting DKD and the graded differences in disease severity across mouse groups, an automatic data analysis method, SOM, or self-organizing map was used to elucidate glomerular transcriptional changes associated with DKD, whereas pairwise bioinformatic analysis was used for DPN. These analyses revealed that enhanced gene expression in several pro-inflammatory networks and reduced expression of development genes correlated with worsening DKD. Although RAS treatment ameliorated the nephropathy phenotype, it did not alter the more abnormal gene expression changes in kidney. Moreover, RAS exacerbated expression of genes related to inflammation and oxidant generation in peripheral nerves. The graded increase in inflammatory gene expression and decrease in development gene expression with DKD progression underline the potentially important role of these pathways in DKD pathogenesis. Since RAS blockers worsened this gene expression pattern in both DKD and DPN, it may partly explain the inadequate therapeutic efficacy of such blockers.
[Expression of Matrix Metalloproteinase-2 And-9 in Kidney of Diabetic Rats].

Feng-qin Dong,Hong Li,Wei-min Cai,Jun Tao,Fen-ping Zhen,Zhe Zhang

DOI: https://doi.org/10.3785/j.issn.1008-9292.2004.03.015

2004-01-01

Abstract:OBJECTIVE:To investigate the expression of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9(MMP-9), transforming growth factor beta(1)(TGF-beta(1)) and IV-collagen (C-IV) in kidneys of diabetic rats. METHODS:Rat diabetic model was induced by streptozotocin (70 mg/kg), and kidneys were examined pathologically and the expressions of MMP- 2, MMP-9, TGF-beta(1) and C-IV were studied by immunohistochemistry. The results were analyzed by imaging quantitative analysis technique. RESULT:Immunoreactive MMP-2 and MMP-9 were mainly expressed in the mesangial cells, endothelial cells, parietal layer of Bowman's capsule and tubular cells. The expression of MMP-2 was significantly weaker in the glomeluri of diabetic rats than that of the control animals (P<0.05), while the expression of TGF-beta(1) and C-IV in the glomeluri of diabetic rats was significantly stronger than that of the controls (P%lt;0.05). The expression of MMP-9 didn't show significant different in glomeluri of the two groups (P>0.05). CONCLUSION:Expression of MMP-2 in glomeluri is decreased in diabetic rats, which may be related to the increased TGF-beta(1) and in turns promote the accumulation of C-IV.
Gene Expression Profiles of Glomerular Endothelial Cells Support Their Role in the Glomerulopathy of Diabetic Mice.

Jia Fu,Chengguo Wei,Weijia Zhang,Detlef Schlondorff,Jinshan Wu,Minchao Cai,Wu He,Margaret H. Baron,Peter Y. Chuang,Zhihong Liu,John Cijiang He,Kyung Lee

DOI: https://doi.org/10.1016/j.kint.2018.02.028

IF: 19.6

2018-01-01

Kidney International

Abstract:Endothelial dysfunction promotes the pathogenesis of diabetic nephropathy (DN), which is considered to be an early event in disease progression. However, the molecular changes associated with glomerular endothelial cell (GEC) injury in early DN are not well defined. Most gene expression studies have relied on the indirect assessment of GEC injury from isolated glomeruli or renal cortices. Here, we present transcriptomic analysis of isolated GECs, using streptozotocin-induced diabetic wildtype (STZ-WT) and diabetic eNOS-null (STZ-eNOS(-/-)) mice as models of mild and advanced DN, respectively. GECs of both models in comparison to their respective nondiabetic controls showed significant alterations in the regulation of apoptosis, oxidative stress, and proliferation. The extent of these changes was greater in STZ-eNOSL/L than in STZ-WT GECs. Additionally, genes in STZ-eNOS(-/-) GECs indicated further dysregulation in angiogenesis and epigenetic regulation. Moreover, a biphasic change in the number of GECs, characterized by an initial increase and subsequent decrease over time, was observed only in STZ-eNOS(-/-) mice. This is consistent with an early compensatory angiogenic process followed by increased apoptosis, leading to an overall decrease in GEC survival in DN progression. From the genes altered in angiogenesis in STZ-eNOS(-/-) GECs, we identified potential candidate genes, Lrg1 and Gpr56, whose function may augment diabetes-induced angiogenesis. Thus, our results support a role for GEC in DN by providing direct evidence for alterations of GEC gene expression and molecular pathways. Candidate genes of specific pathways, such as Lrg1 and Gpr56, can be further explored for potential therapeutic targeting to mitigate the initiation and progression of DN.
Network-based identification and prioritization of key transcriptional factors of diabetic kidney disease

Ikhlak Ahmed,Mubarak Ziab,Sahar Da'as,Waseem Hasan,Sujitha P Jeya,Elbay Aliyev,Sabah Nisar,Ajaz A Bhat,Khalid Adnan Fakhro,Ammira S Alshabeeb Akil

DOI: https://doi.org/10.1016/j.csbj.2022.12.054

2023-01-02

Abstract:Diabetic nephropathy (DN) is one of the most established microvascular complications of diabetes and a key cause of end-stage renal disease. It is well established that gene susceptibility to DN plays a critical role in disease pathophysiology. Therefore, many genetic studies have been performed to categorize candidate genes in prominent diabetic cohorts, aiming to investigate DN pathogenesis and etiology. In this study, we performed a meta-analysis on the expression profiles of GSE1009, GSE30122, GSE96804, GSE99340, GSE104948, GSE104954, and GSE111154 to identify critical transcriptional factors associated with DN progression. The analysis was conducted for all individual datasets for each kidney tissue (glomerulus, tubules, and kidney cortex). We identified distinct clusters of susceptibility genes that were dysregulated in a renal compartment-specific pattern. Further, we recognized a small but a closely connected set of these susceptibility genes enriched for podocyte differentiation, several of which were characterized as genes encoding critical transcriptional factors (TFs) involved in DN development and podocyte function. To validate the role of identified TFs in DN progression, we functionally validated the three main TFs (DACH1, LMX1B, and WT1) identified through differential gene expression and network analysis using the hyperglycemic zebrafish model. We report that hyperglycemia-induced altered gene expression of the key TF genes leads to morphological abnormalities in zebrafish glomeruli, pronephric tubules, proximal and distal ducts. This study demonstrated that altered expression of these TF genes could be associated with hyperglycemia-induced nephropathy and, thus, aids in understanding the molecular drivers, essential genes, and pathways that trigger DN initiation and development.
Glomerular Gene Expression Profiles in Patients with Diabetic Nephropathy

ZH Liu,YC Wu,J Su,ZH Chen,LS Li

DOI: https://doi.org/10.3969/j.issn.1006-298x.2004.06.002

2004-01-01

Abstract:Objective:To compare the differences of glomerular gene expression profiles between patients with diabetic nephropathy (DN) and normal controls, and to investigate its changes in the progression of DN. Methodology:Three DN patients presented respectively with microalbuminuria, overt proteinuria or renal function damage were selected in order to clarify the relationship between the gene expression profiles and the clinical course. Normal donor kidneys were used as controls and were sex and age matched with the patients. Total RNA was isolated from glomeruli and applied for gene expression profiling by Affymetrix U133A arrays. Results:A total of 182 genes varied significantly in glomeruli derived from DN patients, comparing with the normal controls (P0.01). There were 3 distinct patterns within the 182 genes appeared as up-regulated pattern, down-regulated pattern and one special pattern including genes with extremely lower expression in DN patients. The 182 genes were involved primarily in cellular glucose metabolism, lipid metabolism, extra-cellular matrix modulation, cell proliferation and some cytokines, especially in lipid metabolism. Some genes varied in parallel with the severity of clinical manifestations in the patients. Interestingly, the mRNA level of TGF-β1 did not change obviously in the glomeruli taken from DN patients. Conclusion:We first reported the gene expression profiles of glomeruli obtained from patients with DN. It was highlighted point that the genes related to glucose metabolism, lipid metabolism, extracellular matrix modulation, cell proliferation and some cytokines were changed in the gene expression profile of DN glomeruli. The fluctuation of some DN-related gene levels has relationship with the clinical course of DN.
Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice

Yi Lin,Makoto Kuro-o,Zhongjie Sun

DOI: https://doi.org/10.1210/en.2013-1053

IF: 5.051

Endocrinology

Abstract:Klotho is a recently discovered anti-aging gene and is primarily expressed in kidneys. In humans, the klotho level decreases with age whereas the prevalence of chronic kidney disease (CKD) increases with age. Diabetic nephropathy is the most common form of CKD, which leads to end-stage renal disease. A decrease in klotho has been found in kidneys of patients with diabetic nephropathy. The purpose of this study is to assess whether klotho gene deficiency affects early diabetic nephropathy in a mouse of model of type 1 diabetes induced by streptozotocin (STZ). Male KL(+/-) mutant and wild-type mice (6-8 weeks) were injected with multiple low doses of STZ. Renal functions and renal blood flow were assessed. Kidneys were collected for histological examination and molecular assays of TGFβ1 and mammalian targets of rapamycin (mTOR) signaling. Klotho deficiency in KL(+/-) mutant mice exacerbated STZ-induced increases in urine albumin, blood urea nitrogen, expansion of mesangial matrix in renal glomeruli, and kidney hypertrophy, suggesting a protective role of klotho in kidney function and structure. Klotho deficiency did not affect renal blood flow. Notably, klotho deficiency significantly increased phosphorylation of Smad2, indicating enhanced TGFβ1 signaling in kidneys. Klotho deficiency also increased phosphorylation of mTOR and S6 (a downstream effector of mTOR), indicating enhanced mTOR signaling in kidneys of early diabetic mice. Thus, klotho gene deficiency may make kidneys more susceptible to diabetic injury. Klotho gene deficiency exacerbated early diabetic nephropathy via enhancing both TGFβ1 and mTOR signaling in kidneys.
DNA Microarray Analysis of the Gene Expression Profile of Kidney Tissue in a Type 2 Diabetic Rat Model

Zheng Shen,Shuyun Zhang,Chao Chun Zou,Wei Zhong Gu,Shi Qiang Shang

DOI: https://doi.org/10.3892/mmr.2010.367

IF: 3.423

2010-01-01

Molecular Medicine Reports

Abstract:The aim of this study was to determine differences in the gene expression profile of kidney tissue from type 2 diabetes mellitus (T2D) and control rats using DNA microarray analysis. Total RNA was extracted from the kidney tissue of the T2D and control rats using the original single step method. cDNA retro-transcribed from an equal quantity of mRNA was labeled with Cy5 and Cy3 fluorescence and served as the probes. The mixed probes were hybridized to a DNA microarray. Fluorescence signals were scanned by an ScanArray 4000 laser scanner and further analyzed by QuantArray software. Apoptotic cells were detected in situ using the Roche TUNEL assay. Serum glucose, ApoAI, ApoB, ApoA1/ApoB, cholesterol and triglyceride levels were significantly higher in the T2D rats than in the controls, but there were no significant differences in serum insulin. When the kidney tissue was screened using the DNA microarray, differential expression was found for 41 genes. Five genes in the T2D rats were upregulated by 2-fold compared to the control rats, while 36 genes were down-regulated by 0.5-fold. Moreover, in the renal tubular epithelial cells, there was a significantly greater number of TUNEL-positive cells in the T2D group than in the control group. A total of 41 genes are associated with the occurrence and development of T2D and diabetic nephropathy. The present study suggests that examining differences in gene expression profiles is of benefit to the diagnosis, treatment and prevention of T2D, diabetic nephropathy and other T2D complications.
Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats

Omar Abdul-Rahman,Maria Sasvari-Szekely,Agota Ver,Klara Rosta,Bernadett K Szasz,Eva Kereszturi,Gergely Keszler

DOI: https://doi.org/10.1186/1471-2164-13-81

IF: 4.547

2012-02-27

BMC Genomics

Abstract:Background: There has been an increasing body of epidemiologic and biochemical evidence implying the role of cerebral insulin resistance in Alzheimer-type dementia. For a better understanding of the insulin effect on the central nervous system, we performed microarray-based global gene expression profiling in the hippocampus, striatum and prefrontal cortex of streptozotocin-induced and spontaneously diabetic Goto-Kakizaki rats as model animals for type 1 and type 2 diabetes, respectively. Results: Following pathway analysis and validation of gene lists by real-time polymerase chain reaction, 30 genes from the hippocampus, such as the inhibitory neuropeptide galanin, synuclein gamma and uncoupling protein 2, and 22 genes from the prefrontal cortex, e.g. galanin receptor 2, protein kinase C gamma and epsilon, ABCA1 (ATP-Binding Cassette A1), CD47 (Cluster of Differentiation 47) and the RET (Rearranged During Transfection) protooncogene, were found to exhibit altered expression levels in type 2 diabetic model animals in comparison to non-diabetic control animals. These gene lists proved to be partly overlapping and encompassed genes related to neurotransmission, lipid metabolism, neuronal development, insulin secretion, oxidative damage and DNA repair. On the other hand, no significant alterations were found in the transcriptomes of the corpus striatum in the same animals. Changes in the cerebral gene expression profiles seemed to be specific for the type 2 diabetic model, as no such alterations were found in streptozotocin-treated animals. Conclusions: According to our knowledge this is the first characterization of the whole-genome expression changes of specific brain regions in a diabetic model. Our findings shed light on the complex role of insulin signaling in fine-tuning brain functions, and provide further experimental evidence in support of the recently elaborated theory of type 3 diabetes.
The Renal TGF-β System in the db/db Mouse Model of Diabetic Nephropathy

Margo P. Cohen,Kumar Sharma,Jia Guo,Babiker O. Eltayeb,Fuad N. Ziyadeh

DOI: https://doi.org/10.1159/000020527

1998-05-22

Nephron Experimental Nephrology

Abstract:The prosclerotic cytokine transforming growth factor beta 1 (TGF-beta1) has been causally implicated in renal pathobiology in diabetes. We sought evidence that the TGF-beta system participates in the nephropathic process in the db/db mouse, a hyperinsulinemic model of genetic diabetes that develops abnormalities in renal morphology and function that parallel those in human diabetic nephropathy. In support of this hypothesis, we found that steady state levels of mRNA encoding the TGF-beta type II receptor were significantly increased in renal cortex from db/db diabetic mice. Additionally, the translated TGF-beta type II receptor protein, assessed by immunoblot, also was increased in diabetic kidneys. However, in contrast to rodents with insulin-deficient diabetes, steady state levels of mRNA encoding TGF-beta1 in the renal cortex of diabetic db/db mice did not differ from those in cortex from nondiabetic (db/m) littermate controls. Further, concentrations of TGF-beta protein, measured by immunoassay and bioassay, were significantly lower in extracts prepared from renal cortex of diabetic animals compared with those from nondiabetic controls. Urine and serum concentrations of immunoreactive TGF-beta1 also were reduced in diabetic mice. The findings are consistent with upregulation of TGF-beta type II receptor activity as a consequence of hyperglycemia in the hyperinsulinemic db/db mouse and suggest that hyperinsulinemia inhibits TGF-beta1 production. The results further suggest that type II receptor upregulation is a contributing factor to the increased gene expression of renal cortical mRNAs encoding the extracellular matrix proteins fibronectin and alpha 1 (IV) collagen and to the renal abnormalities observed in this animal model.
Impact of genetic background on nephropathy in diabetic mice

Susan B. Gurley,Sharon E. Clare,Kamie P. Snow,Ann Hu,Timothy W. Meyer,Thomas M. Coffman

DOI: https://doi.org/10.1152/ajprenal.00204.2005

2006-01-01

Abstract:With the goal of identifying optimal platforms for developing better models of diabetic nephropathy in mice, we compared renal effects of streptozotocin (STZ)-induced diabetes among five common inbred mouse strains (C57BL/6, MRL/Mp, BALB/c, DBA/2, and 129/SvEv). We also evaluated the renal consequences of chemical and genetic diabetes on the same genetic background (C57BL/6). There was a hierarchical response of blood glucose level to the STZ regimen among the strains (DBA/2 > C57BL/6 > MRL/MP > 129/SvEv > BALB/c). In all five strains, males demonstrated much more robust hyperglycemia with STZ than females. STZ-induced diabetes was associated with modest levels of albuminuria in all of the strains but was greatest in the DBA/2 strain, which also had the most marked hyperglycemia. Renal structural changes on light microscopy were limited to the development of mesangial expansion, and, while there were some apparent differences among strains in susceptibility to renal pathological changes, there was a significant positive correlation between blood glucose and the degree of mesangial expansion, suggesting that most of the variability in renal pathological abnormalities was because of differences in hyperglycemia. Although the general character of renal involvement was similar between chemical and genetic diabetes, Akita mice developed more marked hyperglycemia, elevated blood pressures, and less variability in renal structural responses. Thus, among the strains and models tested, the DBA/2 genetic background and the Akita ( Ins2 +/C96Y ) model may be the most useful platforms for model development.

urology & nephrology,physiology
Altered expression of histone and synaptic plasticity associated genes in the hippocampus of streptozotocin-induced diabetic mice

Jency Thomas,Manohar L Garg,Doug W Smith

DOI: https://doi.org/10.1007/s11011-013-9418-y

Abstract:Accumulating evidence indicates that hyper-glycaemia is deleterious to brain function, in particular to the hippocampus. It is thought this hippocampal dysfunction may contribute to hyperglycaemia related cognitive impairment, such as that which manifests with diabetes. In the present study, we investigated the effects of diabetes-related hyperglycaemia on hippocampal gene expression, in order to identify potential mechanisms that might be associated with the cognitive dysfunction that develops with diabetes mellitus. Genome-wide gene expression profiling was carried out on the hippocampi from streptozotocin (STZ)-induced diabetic mice, and from vehicle treated control mice. Genes of interest that satisfied expression fold-change and statistical criteria, and that were considered to be potentially associated with cognitive function, were further tested by real time, quantitative polymerase chain reaction (qPCR) analysis. We found that STZ-induced diabetes resulted in decreased hippocampal expression of genes involved in epigenetic regulation and synaptic plasticity, for example, histone deacetylases and glycogen synthase kinase 3 beta (HDACs and GSK3β). We also found increased expression of genes involved in signalling cascades related to cell growth, cell survival and energy metabolism, such as neurotropic tyrosine kinase receptor type 2, apolipoprotein E, and protein tyrosine phosphatase receptor type (Ntrk2, APOE, PTPRT). To our knowledge this is the first study to demonstrate a gene expression profile implicating epigenetic modifications and alterations of synaptic plasticity associated genes in diabetes mellitus. The present study will improve our understanding of the neural mechanisms that might underpin diabetes-related cognitive dysfunction.

Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.

Comparison Of Glomerular And Podocyte Mrna Profiles In Streptozotocin-Induced Diabetes

Specific Changes of Somatostatin Mrna Expression in the Frontal Cortex and Hippocampus of Diabetic Rats

Expression Changes Of Mitogen-Actilvated Protelin Kinase Phosphatase-1 (Mkp-1) In Myocardium Of Streptozotocin-Induced Diabetic Rats

Studies on somatostatin mRNA expression in frontal cortex of diabetic rats model]

Gene expression profiling in glomeruli of diabetic nephropathy rat

Study on Gene Expression Profile in Renal Cortex in STZ Induced Diabetic Nephropathy Rats by Cdna Microarray (Genechip)

Gene expression of proteins handling the calcium homeostasis in the diabetic rat heart

Changes of TGF - β1 , Vimentin and Desmin Gene Expression in the Renal Cortex of Streptozotocin - induced Diabetic Rats

Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease

Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects

[Expression of Matrix Metalloproteinase-2 And-9 in Kidney of Diabetic Rats].

Gene Expression Profiles of Glomerular Endothelial Cells Support Their Role in the Glomerulopathy of Diabetic Mice.

Network-based identification and prioritization of key transcriptional factors of diabetic kidney disease

Glomerular Gene Expression Profiles in Patients with Diabetic Nephropathy

Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice

DNA Microarray Analysis of the Gene Expression Profile of Kidney Tissue in a Type 2 Diabetic Rat Model

Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats

The Renal TGF-β System in the db/db Mouse Model of Diabetic Nephropathy

Impact of genetic background on nephropathy in diabetic mice

Altered expression of histone and synaptic plasticity associated genes in the hippocampus of streptozotocin-induced diabetic mice